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a b s t r a c t
The involvement of environmental factors such as endocrine disrupting chemicals (EDCs) in the timing
of onset of puberty is suggested by recent changes in age at onset of puberty and pattern of distribution
that are variable among countries, as well as new forms of sexual precocity after migration. However, the
evidence of association between early or late pubertal timing and exposure to EDCs is weak in humans,
possibly due toheterogeneity of effects likely involvingmixtures and incapacity to assess fetal or neonatal
exposure retrospectively. The neuroendocrine system which is crucial for physiological onset of puberty
is targeted by EDCs. These compounds also act directly in the gonads and peripheral sex-steroid sensitive
tissues. Feedbacks add to the complexity of regulation so that changes in pubertal timing caused by EDCs
can involve both central andperipheralmechanisms. In experimental conditions, several neuroendocrine
endpoints are affected by EDCs though only few studies including from our laboratory aimed at EDC
involvement in the pathophysiology of early sexualmaturation. Recent observations support the concept
that EDC cause disturbed energy balance and account for the obesity epidemic. Several aspects are linking
this system and the reproductive axis: coexisting neuroendocrine and peripheral effects, dependency on
fetal/neonatal programming and the many factors cross-linking the two systems, for instance leptin,
adiponectin, Agouti Related Peptide (AgRP). This opens perspectives for future research and, hopefully,
measures preventing the disturbances of homeostasis caused by EDCs.
© 2010 Published by Elsevier Ireland Ltd.
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1. Introduction: rationale for endocrine disruption of
pubertal timing
Puberty is the life period when pituitary–gonadal maturation
leads to a series of physical changes and ultimately, achievement
of reproductive capacity. A central event in the onset of puberty is
0303-7207/$ – see front matter © 2010 Published by Elsevier Ireland Ltd.
doi:10.1016/j.mce.2010.02.033
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an increase in frequency and amplitude of Gonadotropin Releas-
ing Hormone (GnRH) secretion in the hypothalamus. This event
is controlled by redundant inhibitory or excitatory mechanisms
that respectively disappear or appear at the onset of puberty
(Bourguignon, 2004). It is generally agreed that variations in puber-
tal timing within a physiological 5-year period are predominantly
determined by genetic factors while environmental factors play
a comparatively minor role (Parent et al., 2003). A robust land-
mark of environmental effects on pubertal timing arose through
the secular advance in menarcheal age. Because this observation
was made between the mid-19th and the mid-20th centuries both
in USA and Western Europe and more recently in developing coun-
tries (Parent et al., 2003), the likely explanation was thought to
be improvement in health and nutritional status with industri-
alization. Accordingly, the end or slowdown of this process seen
between 1960 and 2000 was expected. Around the year 2000 how-
ever, two large American studies provided evidence of earlier onset
of puberty (Herman-Giddens et al., 1997; Lee et al., 2001). Very
recently relatively similar ﬁndings were obtained in Denmark and
Belgium (Aksglaede et al., 2009; Roelants et al., 2009). As opposed
to the previous changes, the recent observations were heteroge-
neous: they could differ among countries; initial signs such as onset
of breast development were more affected than subsequent signs
such as menarcheal age (Herman-Giddens et al., 1997; Lee et al.,
2001; Aksglaede et al., 2009; Roelants et al., 2009); age distribution
showed skewing towards earlier ages for initial signs and towards
later ages for ﬁnal signs (Roelants et al., 2009; Papadimitriou et al.,
2008). Because those changes in pubertal timing were concomi-
tant with the epidemic of obesity in USA, the pathophysiological
involvement of fat mass, possibly through leptin (Herman-Giddens
et al., 1997; Lee et al., 2001; Himes, 2006) was hypothesized in that
country. However, the recent changes in pubertal timing in Den-
mark were not associated with changes in adiposity (Aksglaede et
al., 2009). Thus other factors including endocrine disrupting chem-
icals (EDCs) could be involved (Teilmann et al., 2002).
Additional evidence of environmental effects onpubertal timing
in humans came from studies in children migrating for interna-
tional adoption. As cohorts, they appeared to mature earlier than
children in the foster countries and in the countries of origin (Proos
et al., 1991; Parent et al., 2003). Also, sexual precocity requiring
GnRH agonist therapy was much more common in those migrat-
ing children than in others (Krstevska-Konstantinova et al., 2001;
Teilmann et al., 2006). Based on increased serum levels of DDE, a
derivative of the estrogenic insecticide DDT found among migrat-
ing children, we hypothesized that early exposure to this EDC
and subsequent withdrawal due to migration could account for a
neuroendocrinepathogeneticmechanismof secondary central pre-
cocious puberty (Krstevska-Konstantinova et al., 2001; Parent et al.,
2003). Many other EDCs however could possibly be involved and
could result in peripheral precocity as well (see below). The bias
accounting for DDT study came from the very long half-life of its
derivative DDE. Moreover, it was likely that other factors including
recovery from earlier nutritional as well as psychosocial depriva-
tion could play some role in this particular condition (Dominé et
al., 2006).
2. Sexually dimorphic evidence of endocrine disruption of
pubertal timing in humans
It is challenging to link exposure to particular EDCs and health
issues such as disorders of pubertal timing for several reasons
(Buck Louis et al., 2008; Diamanti-Kandarakis et al., 2009). Humans
as well as animals are likely exposed to a variety of EDCs acting
as mixtures with time-related changes in compounds and doses.
Mixtures result in more than additive effects since compounds
mixed at concentrations that were inactive when used as sin-
gle EDCs were shown to become active when used as mixtures
(Kortenkamp, 2008). The study of mixtures, however, is complex
and laborious. So far neuroendocrine studies have been performed
with single classes of EDCs only. When exposure is assessed at the
time of pubertal disorders, there has been a very long period since
fetal/perinatal life, the most critical time for EDC effects. Though
such factors could affect the relevance of the studied relationship
between EDCs and pubertal disorders, we will review the avail-
able information that is mainly based on the study of single EDCs.
Prenatal and postnatal exposure will be separated whenever pos-
sible as well as effects in males and females. Sexual dimorphism
is indeed a critical issue when EDC effects are considered. As a
whole, EDCs appear towork either as estrogen agonists or as andro-
gen antagonists with the ratio Estrogen/Androgen actions as an
ultimate determinant of EDC effects (Rivas et al., 2002). Consis-
tent with this concept is the observation that premature breast
Table 1
Variations in pubertal timing in relation with pre- and/or post-natal exposure of female humans to endocrine disrupters.
Pubertal timing Early Normal Delayed








B2 (Wolff et al., 2008)
B2 (Krstevska-Konstantinova et al., 2001) Menarche and B3 (Gladen et al., 2000)
Methoxychlor Monkey (Golub et
al., 2003)





et al., 2004; Yang et
al., 2005)
B2/menarche (Den
Hond et al., 2002); B2
(Wolff et al., 2008)
Menarche and B3 (Gladen et al., 2000)





B2 (Leijs et al.,
2008)
B2 (Den Hond et
al., 2002)




Menarche (Strom et al.,
2001)
B2 (Wolff et al.,
2008)
DDE: dichlorodiphenyldichloroethene; DDT: dichlorodiphenyltrichloroethane; PBB: polybrominated biphenyl; PCB: polychlorinated biphenyl; and B2, B3: Tanner’s stages 2
and 3 of breast development.
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Table 2
Variations in pubertal timing in relation with pre- and/or post-natal exposure of male humans to endocrine disrupters.
Pubertal timing Early Normal Delayed
Exposure Prenatal Postnatal Prenatal Postnatal Prenatal Postnatal
DDE (+DDT) G3-5, PHV (Gladen et al., 2000)
PCBs
G3-5, PHV (Gladen et al., 2000) Penile length (Guo et
al., 2004)
P and G (Den Hond
et al., 2002)G, TV (Mol et al., 2002)
Dioxin P and G (Den Hond
et al., 2002)
DDE: dichlorodiphenyldichloroethene; DDT: dichlorodiphenyltrichloroethane; PCB: polychlorinated biphenyl; G: Tanner’s stage of genital development; P: Tanner’s stage
of pubic hair development; PHV: peak height velocity; and TV: testicular volume.
development can occur after exposure to phthalates that are con-
sidered to act primarily as androgen antagonists (Colon et al.,
2000). Further, an estrogenic compound such as DDT can gener-
ate the anti-androgenic sub-product DDE that can also indirectly
reﬂect previous exposure to DDT, further complicating the eluci-
dation of estrogenic versus anti-androgenic effects (Rasier et al.,
2008).
Virtually, any clinical evidence of pubertal development (except
testicular growth) can result from either centrally driven mat-
uration involving the hypothalamic–pituitary system or direct
peripheral interaction in the tissues targetedby sex steroids or both
mechanisms. Here, the clinical manifestations will be reviewed
irrespective of the underlying mechanism. In a subsequent sec-
tion, the neuroendocrine mechanisms will be delineated. More
data were obtained in girls (Table 1) than in boys (Table 2). This
could involve methodological biases since a precise timer of matu-
ration is provided by menarcheal age in girls who also experience
more obvious onset of puberty with the development of breasts
as opposed to the less perceptible increase in testicular volume in
boys (Parent et al., 2003).
While themajority of EDCs studied in girls accounted for normal
or early timing (Table 1), dioxins and phytoestrogens were associ-
ated with delayed timing of breast development (Den Hond et al.,
2002; Leijs et al., 2008; Wolff et al., 2008). Menarcheal age how-
ever did not seem to be affected by dioxins or phytoestrogens in
the same studies (Den Hond et al., 2002; Leijs et al., 2008) and in
others (Strom et al., 2001; Warner et al., 2004). Likewise, disso-
ciation between normal timing of breast development and early
menarche was reported in relation to exposure to PBBs (Blanck et
al., 2000). These ﬁndings emphasize the importance of studying
different pubertal signs possibly involving different mechanisms
at several times throughout the pubertal process. Except one study
reporting early menarche in relation to exposure to PCBs (Denham
etal., 2005), this EDCwas found tobeassociatedwithnormal timing
of both breast development andmenarche (Gladen et al., 2000;Den
Hond et al., 2002; Vasiliu et al., 2004; Yang et al., 2005; Wolff et al.,
2008). Early breast development (Krstevska-Konstantinova et al.,
2001) and early menarche (Vasiliu et al., 2004; Ouyang et al., 2005)
were reported in relation to exposure to DDT and or DDE whereas
normal pubertal timing was found by others (Gladen et al., 2000;
Denham et al., 2005; Wolff et al., 2008). In the female monkey,
delayed nipple growth and short follicular phase were seen after
exposure to methoxychlor (Golub et al., 2003). Overall, those stud-
ies did not enable to show different effects depending on prenatal
or postnatal period of exposure to the EDCs.
In boys, the few studies available (Table 2) suggest no effects of
DDT, DDE and dioxins (Gladen et al., 2000; Den Hond et al., 2002).
Exposure to PCBs was found to be associated with either normal
(Gladen et al., 2000; Mol et al., 2002) or delayed timing (Den Hond
et al., 2002; Guo et al., 2004) of male pubertal development.
3. Direct and indirect EDC effects on neuroendocrine
maturation at puberty
Puberty involves a cascade of physiological events result-
ing from CNS and neuroendocrine maturation (Table 3).
Because sex steroids can act at the different levels of the
hypothalamic–pituitary–gonadal system, the imbalance between
estrogen and androgen effects caused by EDCs (Rivas et al., 2002)
potentially affects all those levels. Gender dimorphism is another
important aspect both peripherally and centrally.
Changes in gonads and peripheral tissues responsive to sex
steroids were the ﬁrst endpoints studied to show EDC effects.
Direct disruption of the peripheral reproductive system involves
predominantly effects mimicking estrogens in the female while
counteractedandrogeneffects are involvedperipherally in themale
(Diamanti-Kandarakis et al., 2009). Since the reproductive system
is regulated by feedback loops between gonads and peripheral tis-
sues on the one hand and pituitary gland, hypothalamus and CNS
on the other hand, direct peripheral effects of EDCs can secondar-
Table 3
Some possible mechanisms of EDC maturational effects on the hypothalamic–pituitary–gonadal system in female and male individuals.
Level possibly targeted by EDCs Developmental effects of increased Estrogen/Androgen balance Mechanisms
Female Male
CNS: suprahypothalamic afferences Structural changes? Primary central/neuroendocrine
or
Secondary to altered feedback effects of
gonadal hormones
Hypothalamus: GnRH neurons and
surrounding neurono-glial system
Facilitation (or inhibition) of pulsatile GnRH secretion
Female more sensitive than the male?
Alteration of sexually dimorphic control of ovulation
Pituitary gland: gonadotrophic cells Early pubertal stimulation
or
Increased prepubertal inhibition (negative feedback)
Response to neuroendocr. effects
or
Peripheral feedback
Gonads: sex steroid production/effects
and gametogenesis
Alteration of folliculogenesis Alteration of spermatogenesis Primary peripheral
or




of androgen sensitive tissues
(penis, prostate)
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Table 4
In vitro evidence of neuroendocrine disruption of the reproductive system.
EDC Expos. Sex Endpoint
PCBs GT1–7 neurons – Aroclor1221: increased GnRH mRNAs and peptide release; neurite outgrowth.
Aroclor 1254: biphasic effects and neurotoxicity (Gore et al., 2002)
GT1–7 neurons – Early elevation and late reduction of GnRH release; apoptotic and neurotoxic
effects (Dickerson et al., 2009)
MXC GT1–7 neurons – ER independent reduction of GnRH mRNAs; ER mediated stimulation of GnRH
release (Gore, 2002)
Coumestrol GT1–7 neurons – ERmediated inhibition of GnRH mRNA expression (Bowe et al., 2003)
DDT Rat hyp. explants F ER and AhR receptor mediated stimulation of pulse frequency of GnRH
secretion and glutamate-evoked release (Rasier et al., 2007, 2008)
Dioxin Adult rat F TCDD in vitro: no effect on pulsatile GnRH release (Trewin et al., 2007)
MXC: methoxychlor; PCBs: polychlorinated biphenyls; ER: estrogen receptor; AhR: arylhydrocarbon receptor; DDT: dichlorodiphenyltrichloroethane; and TCDD: 2,3,7,8-
tetrachlorodibenzo-p-dioxin.
ily inﬂuence central mechanisms through changes in endogenous
peripheral hormones. Consequently, changes in neuroendocrine
and pituitary function could result indirectly from altered periph-
eral feedback.
Changes in hypothalamic and pituitary function could also
result directly from EDC neuroendocrine effects. Centrally, the
neuroendocrine control of reproduction through the preovulatory
gonadotropin surge and its alteration following exposure to sex
steroids during fetal or perinatal life has been known for several
decades as a speciﬁc female feature (Gorski, 1968). In such condi-
tions, changes in gonadal and peripheral tissue function could be
determinedbyEDCneuroendocrine effects. Due toobvious limits in
assessment of neuroendocrine function in the clinical setting, the
use of experimental models is required to tackle neuroendocrine
effects of EDC.
4. Experimental models of EDC neuroendocrine effects on
the reproductive axis
In Tables 4 and 5 are summarized some ﬁndings providing
experimental evidence of EDC neuroendocrine effects. The avail-
able data are quite heterogeneous as far as the studied EDCs, the
experimental models and the endpoints. Since, so far, only few
studies have addressed the issue of neuroendocrine disruption of
sexual maturation, we have extended our review of the mecha-
Table 5
In vivo evidence of neuroendocrine disruption of the reproductive system.
EDC Expos. Sex Endpoint
DES Quail embryo M Reduced vasotocin in medial preoptic nucleus and bed nucleus of stria
terminalis; suppression of male copulatory behavior (Viglietti-Panzica et al.,
2005)
MXC Fetal ewe F Delayed LH surge (Savabieasfahani et al., 2006) – secondary to altered
folliculogenesis?
BPA Fetal ewe F Reduced magnitude of LH surge (Savabieasfahani et al., 2006) – secondary to
altered folliculogenesis?
Fetal rat M Increased ERmRNA expression in POA (Ramos et al., 2003)
Fetal/neonatal mouse F Decline in tyrosine hydroxylase neurons in POA and suppression of sex-related
rearing behavior (Rubin et al., 2006)
Neonatal rat M Increased anxiety behavior and body weight (Patisaul and Bateman, 2008)
Neonatal rat M/F Reduced hypothalamic Kiss-1 expression (Navarro et al., 2009)
Adult OVX rat F Increased progesterone receptor expression in POA and VMN; reduced sexual
receptivity (Funabashi et al., 2003)
DDT Neonat. mouse M Increased brain estrogen receptor (Mussi et al., 2005)
Neonat. ﬁsh M/F Increased activity and expression of brain aromatase and male to female sex
reversal (Kuhl et al., 2005)
Neonat. rat F Increased frequency of pulsatile GnRH secretion, sexual precocity, disturbed
estrus cyclicity (Rasier et al., 2007)
PCBs Fetal rat F Aroclor 1221: increased GnRH mRNAs in POA-anterior hypothalamus and
unchanged timing of vaginal opening; Aroclor 1254: no effects (Gore, 2008)
Fetal rat F Aroclor 1221: altered female mating behavior (Steinberg et al., 2007) and
reduced proestrus LH surge (Steinberg et al., 2008)
Adult ﬁsh M Aroclor 1254: reduced tryptophan hydroxylase activity and GnRH content in
POA (Khan and Thomas, 2001)
Dioxin Fish larvae TCDD: prevention of brain aromatase upregulation by estradiol (Cheshenko et
al., 2007)
Fetal rat M TCDD: increased content and reduced release of GnRH by hypothalamic
explants (Clements et al., 2009)
Isoﬂavone Adult rat F Increased ER receptors in PVN; reduced upregulation of oxytocin receptors
via ER in VMN; reduced sexual receptivity (Patisaul et al., 2001)
Coumestrol Adult OVX rat F Reduced multiunit electrical activity in hypothalamus and inhibition of LH
pulse amplitude and frequency (McGarvey et al., 2001)
MXC: methoxychlor; BPA: bisphenol A; DES: diethylstilbestrol; PCBs: polychlorinated biphenyls; PVN: paraventricular nucleus; VMN: ventromedial nucleus; POA: preoptic
area; OVX: ovariectomized; ER: estrogen receptor; DDT: dichlorodiphenyltrichloroethane; and TCDD: 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Author's personal copy
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nisms of EDC effects to the overall neuroendocrine control of the
reproductive system.
4.1. In vitro studies
In vitro models allowed direct evaluation of EDC effects on
neurono-glial function (Table 4). A debated question is as to
whether sex steroids and EDCs that have the estrogen receptor
as common target inﬂuence the GnRH neuron directly or indi-
rectly. In a previous review,we concluded thatGnRHneurons could
be directly involved in responding to estrogens (Matagne et al.,
2003).Maturational characteristics could inﬂuenceestrogeneffects
on GnRH neurons. GT1 cells, a model for GnRH neurons that are
responsive to estrogens andEDCs, havebeenobtained from immor-
talizationat anembryonic stageandare somehowdevelopmentally
arrested. Direct early responsiveness of GnRHneurons to estrogens
at early developmental stage is supported by a recent study show-
ing that neurogenesis in cultured olfactory placode was directly
stimulatedby estradiol (Agc¸a et al., 2008). Later in adulthood, estro-
gen effects on GnRH neurons may become indirect since studies
with cell speciﬁcdeletionof thedifferentERsubtypes indicated that
estradiol positive feedback at the time of the preovulatory surge
primarily involved other estrogen responsive cells than GnRH neu-
rons (Herbison, 2008). Species differences could also occur since it
was shown recently that orchidectomycaused increasedamplitude
of pulsatile GnRH release from monkey but not from rat hypotha-
lamic explants (Woller et al., 2010). Using cultured immortalized
GnRH neurons, variable changes in GnRH transcripts and peptide
release were obtained depending on the EDC and the concentra-
tions used, the response being possibly non-linear and biphasic
(Gore et al., 2002; Gore, 2002; Bowe et al., 2003; Dickerson et al.,
2009). PCBs also accounted for neurotoxic effects with increased
expression of cleaved caspase-9 (Gore et al., 2002; Dickerson et
al., 2009). We used hypothalamic explants to study the effects
of DDT, an estrogenic EDC, in relation to sexual maturation. Our
paradigm included axons and terminals of the ﬁnal effector, i.e. the
GnRHneuron (Purnelle et al., 1997) aswell as the afferent neurono-
glial apparatus possibly involved in EDC effects. The explants also
retained some developmental characteristics since they released
GnRH in a pulsatile manner with a frequency increasing from birth
to onset of puberty (Bourguignon et al., 1992). We used hypotha-
lamic explants of immature female rats aged 15 days because they
were found earlier to be responsive to estradiol through an increase
in frequency of pulsatile GnRH secretion (Matagne et al., 2004). In
such conditions, DDT resulted in effects similar to estradiol (Rasier
et al., 2008). However, Trewin et al. (2007) could not observe any
change inpulsatileGnRHsecretioncausedbydioxinusinghypotha-
lamic explants from cycling adult female rats. The age difference
could account for such discrepant observations since we did not
observe at 25 and 50 days the stimulatory estradiol effects seen at
5 and 15 days (Matagne et al., 2004). Though such in vitro mod-
els provided an opportunity to study directly the mechanisms of
neuroendocrine EDC effects, the conditions were not comparable
to those in vivo both in terms of GnRH neuron function/regulation
and environmental exposure to the studied EDCs. The explants or
the immortalized neurons were deafferented from physiological
neurono-glial inputs. Concentrations higher than those toxicologi-
cally relevant in humans were required likely due to low diffusion
in the explants (Matagne et al., 2003). This reinforced the value of
in vivo models.
4.2. In vivo studies and critical periods
Suggestive evidence of EDC neuroendocrine effects was
obtained in vivo by studying physiological processes known to
involve hypothalamic or CNS regulation (Table 5). Except phytoe-
strogen effects thatwere studied in adult animals, the vastmajority
of studies were performed after exposure during fetal and/or early
postnatal life. This is consistent with the concept of critical periods
in early life that appeared to determine the effects of sex steroids
(McCarthy et al., 2009) as well as nutrition (Gluckman and Hanson,
2004) on the homeostasis of reproduction and energy balance. The
neuroendocrine events affected by EDCs in vivo include central,
i.e. gonadotropin-dependent onset of puberty (Rasier et al., 2007;
Gore, 2008), ovulation that is dependent on stimulation by the
gonadotropin surge (Savabieasfahani et al., 2006; Steinberg et al.,
2008) and sexual behavior in males (Viglietti-Panzica et al., 2005)
and females (Patisaul et al., 2001; Funabashi et al., 2003; Rubin et
al., 2006; Steinberg et al., 2007). Not unexpectedly, those three sex-
ually dimorphic processes are likely regulated by sex steroids and
possibly disrupted by EDCs differently in males and females in dif-
ferent species. Prenatal exposure of the ovine fetus to testosterone
caused alteration of pubertal timing and estrus cyclicity through
neuroendocrinealterationof estradiolpositive feedback (Unsworth
et al., 2005), including marked reduction of FOS-positive GnRH
neurons in response to estradiol (Wood et al., 1996). In similar
conditions, fetal lamb exposure to the EDCs methoxychlor or BPA
accounted for delayed or severely reduced LH surge, respectively,
without change in pubertal timing (Savabieasfahani et al., 2006). As
emphasized by the authors, the exposed animals also had ovarian
anomalies, growth retardation and metabolic disorders that could
contribute to disrupted reproductive function. A single prenatal
administrationof PCBmixtureongestational day16causedpostna-
tal growth retardation (Gore, 2008) and disturbed sexual behavior,
prominently in females (Wang et al., 2002; Steinberg et al., 2008).
Behavioral evidence of transgenerational effects came from female
preference of male with no history of exposure, three genera-
tions after the progenitors were exposed to vinclozolin (Crews et
al., 2007). These ﬁndings might suggest epigenetic changes in the
neuroendocrine components of sexual behavior regulation. Direct
evidenceof epigeneticmechanisms in thehypothalamus in relation
with sexual differentiation further provide rationale for studies on
EDC effects on epigenetics of the neuroendocrine system (Murray
et al., 2009).
Other endpoints in experimental studies on neuroendocrine
effects include expression or transcripts of sex steroid receptors
(Patisaul et al., 2001; Funabashi et al., 2003; Ramos et al., 2003;
Mussi et al., 2005) and enzymes involved in sex steroidmetabolism
or dependent on sex steroid effects (Khan and Thomas, 2001; Kuhl
et al., 2005; Rubin et al., 2006). In this respect, aromatase deserves
special attention due to its involvement in the control of sexually
differentiated neuroendocrine functions including sexual behavior
(Balthazart et al., 2006). In the zebra ﬁsh, dioxins were shown to
alter estrogen upregulation of aromatase (Cheshenko et al., 2007).
Several authors including our group have studied direct or indi-
rect appraisal of GnRH synthesis and secretion (Khan and Thomas,
2001; McGarvey et al., 2001; Rasier et al., 2007; Gore, 2008) While
we found that in vivo early postnatal exposure of female rat to DDT,
an estrogenic EDC, resulted in premature developmental increase
in GnRH pulse frequency in vitro (Rasier et al., 2007), Clements
et al. (2009) reported recently that, in male rats, GnRH release in
vitro was reduced after fetal exposure to dioxin, another estro-
genic EDC. This stresses again the diversity of conditions including
gender, compound and period of exposure that could account for
discrepant data. Finally, neuropeptides dependent on sex steroid
effects (Patisaul et al., 2001; Viglietti-Panzica et al., 2005) includ-
ing the recent demonstration of reduced Kiss-1 expression by BPA
(Navarro et al., 2009) and non-sexual aspects of behavior (Patisaul
and Bateman, 2008). In summary, several neuroendocrine studies
on EDC effects were performed but the conclusions drawn from
such studies remain rather limited due to the many variables that
may inﬂuence the response to EDCs, e.g. dose, age at exposure,
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Fig. 1. Schematic illustration of themechanisms of estradiol and o,p′-DDT effects onGnRH secretion. Three pathways are identiﬁedwith both rapid, presumably non-genomic
effects and slow, presumably genomic effects: (1) binding the classical estrogen receptor (ER) and causing genomic effects after activation through the estrogen responsive
element (ERE); (2) binding some ER and interacting with the AMPA subtype of glutamate receptor with subsequent involvement of intracellular kinases; and (3) binding the
aryl hydrocarbon (AHR) orphan dioxin receptor, and cross talking with the E2 signalling machinery to form a functional transcriptional complex in the regulatory region of
ER-responsive genes (Ohtake et al., 2003).
durationof exposure, routeof administration, gender andmixtures.
Comparison between neuroendocrine effects and studies on effects
in other parts of the CNS may help in elucidation of alterations
caused by EDCs during CNS development (Naveau et al., 2010).
5. A rodent model of EDC neuroendocrine effects on sexual
maturation
Using hypothalamic explants of immature female rats aged 15
days, we showed that o,p′-DDT directly stimulated GnRH pulse fre-
quency in vitro. The mechanism (Fig. 1) involved both the ER and
thearyl hydrocarbon receptor (AHR) aswell as theAMPAsubtypeof
glutamate receptors (Rasier et al., 2008). The DDT effects were not
only dose-dependent but also time-dependent with both rapid and
slow effects since the glutamate-evoked release of GnRH increased
as soon as after 7.5min of incubation and further after 4h of incu-
bation (Rasier et al., 2008). These in vitro ﬁndings provided the
rationale for an in vivo study of DDT effects on pubertal timing
througha central/hypothalamicmechanism. Theaimwas toexpose
female rats early and transiently to DDT in order to model the neu-
roendocrine effects of the pesticide that could account for sexual
precocity in girls migrating for international adoption (Krstevska-
Konstantinova et al., 2001; Parent et al., 2003). Because fetal or
early postnatal exposure to testosterone or estradiol would mas-
culinize the CNS and alter the mechanism of estrus cycling, the
animals were exposed to DDT on postnatal days 6–10. We reported
in earlier studies that exposure to estradiol within this age win-
dow resulted in sexually differentiated effects on GnRH secretion
both in vitro and in vivo and subsequent female sexual precocity
(Matagne et al., 2004). In similar age conditions, in vivo exposure
to DDT followed by ex vivo study of GnRH release by hypothala-
mic explants resulted in premature acceleration of pulsatile GnRH
secretion (Rasier et al., 2007). Both vaginal opening and ﬁrst estrus
occurred earlier after exposure to estradiol or DDT though the time
interval between the two events was increased. Our ﬁndings could
involve central as well as peripheral mechanisms of sexual precoc-
ity. In order to obtain further evidence of neuroendocrine effects of
DDT in vivo, the response of pituitary LH to a bolus administration
of synthetic GnRH was studied. LH response was shown to reﬂect
previous stimulation by endogenous GnRH and, in man, increased
LHresponsewas regardedas theevidenceofneuroendocrinematu-
ration leading to the so-called central puberty (Carel et al., 2009). A
different situation occurred in the female rat since neuroendocrine
maturation was associated with a developmental reduction of LH
response, a confounding observationwith LH reduction due to neg-
ative feedback such as seen in peripheral precocity. Nevertheless,
we observed a premature developmental reduction in LH response
after exposure to DDT that possibly resulted from neuroendocrine
effects (Rasier et al., 2007). Based on the rodent model, our inter-
pretation of sexual precocity aftermigration is summarized in Fig. 2
(Parent et al., 2003; Rasier et al., 2006, 2007). During exposure to
DDT, estrogenic effects can account for both peripheral and central
(neuroendocrine) stimulation. However, due to concomitant neg-
ative feedback inhibition at the pituitary level, the central effects
arenot translated intogonadotropin stimulationof theovariesuntil
the pituitary inhibition disappears following migration in a DDT-
free environment. In a study of internationally adopted girls aged
5–8 years before they eventually showed clinical evidence of sex-
ual precocity, Teilmann et al. (2007) reported that serum FSH and
estradiol levels were already elevated in several girls, conﬁrming
early pituitary–ovarian activity after migration. The above mech-
anism is comparable to that operating in other conditions with
peripheral precocious puberty (e.g. congenital adrenal hyperpla-
sia, adrenal or gonadal tumours) followed by secondary central
precocious puberty after the peripheral disorders is cured by med-
ical or surgical treatment (Parent et al., 2003). Consistent with this
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Fig. 2. Schematic representation of the putative mechanism of sexual precocity after transient exposure to the estrogenic insecticide DDT in girls migrating for international
adoption. During exposure to DDT, neuroendocrine maturation is promoted but not translated into ovarian stimulation due to negative feedback inhibition of the pituitary
gonadotropes. After migration in a DDT-free environment, the negative feedback does no longer operate and allows central maturation to lead to gonadotropin-dependent
puberty (modiﬁed from Rasier et al., 2006).
concept, central precocity should not be manifested in conditions
of persisting exposure to DDT. We attempted to demonstrate that
continued administration of DDT to the female rats was not associ-
ated with evidence of precocious central maturation but we failed
due to toxic effects including malnourishment and growth failure
(Rasier et al., 2007).
We previously reviewed the effects of EDCs on sexual matura-
tion in laboratory rodents (Rasier et al., 2006). Peripheral effects
can be biphasic, low doses causing early puberty and high doses
delayed puberty such as shown using triphenyltin in the female rat
(Grote et al., 2006) andphthalates in themale (Geet al., 2007). In the
few studies where hypothalamic pituitary function was assessed,
LH secretionwas reduced togetherwith early vaginal opening after
DES (Kubo et al., 2003) or irregular cycling after BPA (Rubin et al.,
2006). Still, the possibly coexisting central and peripheral effects
remain a matter of confusion. As an example, BPA administration
to neonatal female rats for 4 days resulted in early vaginal opening
and acyclicity but no change in sexual receptivity and FOS induc-
tion in GnRH neurons after steroid priming (Adewale et al., 2009).
This suggested predominant peripheral effects in those conditions
and highlighted the importance of simultaneous study of central
and peripheral effects.
6. Endocrine disruption of puberty and reproduction in
relation to homeostasis of energy balance
The neuroendocrine system in the hypothalamus constitutes a
single place for different aspects of homeostasis including repro-
duction and energy balance. It is also involved, during fetal and
neonatal life, in programming mechanisms accounting for the
“developmental origin of health and diseases” (Gluckman and
Hanson, 2004). Therefore, it appeared interesting to integrate some
of themany connections betweenhomeostasis of reproduction and
homeostasis of energy balance, during both prenatal/neonatal and
postnatal life (Fig. 3).
6.1. Experimental data
Fetal malnourishment as well as fetal exposure to endocrine
disrupters such as DES and BPA were shown to possibly result
in low birth weight, early puberty, ovulatory disorders, obesity
in adulthood and metabolic syndrome (Gluckman and Hanson,
2004; Newbold et al., 2008, 2009; Sloboda et al., 2009; Heindel
and vom Saal, 2009). The consequences of fetal malnourishment
on adult adiposity excess and metabolic syndrome could be pre-
vented by neonatal or early postnatal leptin treatment indicating
the critical role of this peripheral peptide in fetal/neonatal pro-
gramming (Vickers et al., 2005). Leptin has appeared to be not only
an anorexigenic hormone produced by the mature adipocyte but
also a structural organizer of the hypothalamic circuitry controlling
energy balance during a critical period including fetal life and the
ﬁrst 3 weeks of postnatal life in rodents (Bouret et al., 2004; Bouret
and Simerly, 2007). Bouret (2010) hypothesized that anomalies in
early leptin organizational effects in relation with nutritional dis-
turbances during that critical window could predispose to later
obesity andmetabolic disorders. Leptin could also be involved after
fetal/neonatal exposure to sex steroids sinceneonatal androgeniza-
tion resulted in marked reduction of leptin mRNA levels in the
pituitary gland of female rats on days 14 and 22 (Morash et al.,
2001). Further involvement of leptin in relation to sex steroids and
EDCs was suggested by the reduced serum leptin levels observed
neonatally in association with reduced anogenital distance after
fetal exposure to phthalates (Boberg et al., 2008). During postna-
tal life, leptin is also obviously an important link between energy
balance and reproduction. As shown in Fig. 4, facilitatory effects on
GnRH secretion were observed after a single leptin administration
in 15-day-old rats but not at 50 days, further supporting the con-
cept of early critical window before the age of 3 weeks in rodents
(Parent et al., 2003; Lebrethon et al., 2007). Together with leptin as
peripheral messenger, a common hypothalamic mediator of early
EDCeffects on energybalance and reproduction could be theAgouti
Related Peptide (AgRP), an endogenous orexigenic antagonist at
melanocortin receptors. In our laboratory, AgRP treatment in vivo
or in vitro (Fig. 4) was found to cause deceleration of frequency
of pulsatile GnRH secretion from male rat hypothalamic explants
(Lebrethon et al., 2007). This effect was similarly seen in immature
and pubertal animals suggesting a role in the neuroendocrine con-
trol of the reproductive axis but no involvement in the mechanism
ofpuberty. Exposureof fetal andneonatalmice toBPAwas shownto
result in hypomethylation of a metastable epiallele locus upstream
Author's personal copy
J.-P. Bourguignon et al. / Molecular and Cellular Endocrinology 324 (2010) 110–120 117
Fig. 3. Schematic representation of the interactions between homeostasis of reproduction and energy balance as well as hypothalamic effectors and peripheral effectors in
the neuroendocrine mechanisms involved in effects on pubertal timing.
Fig. 4. Upper panel: representative proﬁles of GnRH secretion by hypothalamic explants from 15-day-old male rats incubated in the presence of leptin, ghrelin or Agouti-
related peptide (AgRP). In each condition, the mean± SD interpulse interval is given (number of explants studied). Lower panel: mean interpulse interval observed in vitro
using explants from 15- or 50-day-old male rats injected with leptin, ghrelin or AgRP in vivo. *p<0.05 versus controls (modiﬁed from Lebrethon et al., 2007).
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to the agouti gene thatwas associatedwith increasedectopic agouti
geneexpression (Dolinoyetal., 2007)knownto result inyellowcoat
color and adult obesity (Dolinoy, 2008). Fertility however was not
impaired in those BPA exposure conditions and adult weight was
not studied.
EDCs affect adipocytes directly at different periods of life
through induction of cell differentiation and adipogenesis (Grün et
al., 2006) as well as lipid accumulation in differentiated adipocytes
(Wada et al., 2007). Gestational and lactational exposure to BPA
resulted in increasedadipogenesis atweaning in female rats (Somm
et al., 2009). This is in contrast to the reduced adiposity and
increased insulin sensitivity in mice fed from conception to adult-
hood with a phytoestrogen rich diet (Cederroth et al., 2008). EDC
effects on adipocytes could be increased due to storage in the adi-
pose tissue of several EDCs that are lipophilic. Adiponectin, a factor
protecting against obesity and insulin resistance, could play a role
as well. Using mature abdominal adipocytes in vitro, BPA reduced
the secretion of several adipokines including adiponectin (Hugo et
al., 2008; Ben-Jonathan et al., 2009). Through such an effect, EDC
could facilitate GnRH secretion since immortalized GnRH neurons
were shown to express adiponectin receptors and GnRH release
was reduced in the presence of adiponectin (Wen et al., 2008). The
fetal balance between estrogenic and androgenic steroids that is
disturbed by EDCs can also be directly affected by sex steroids such
as treatment of pregnant ewe with testosterone. In these condi-
tions, pubertal timing in female lambs was shifted from the female
to the male pattern as a function of the degree of virilization of
external genitalia (Kosut et al., 1997). Postnatal events may worsen
the consequences of disturbed programming: postnatal weight
excess due to overfeeding ampliﬁed the reproductive disturbances
following prenatal androgenization of the female lamb (Steckler et
al., 2009).
6.2. Human data
In the clinical setting, the interaction between nutrition and
reproduction has been viewed for almost 40 years as an issue for
adolescent and adult females in the perspective of energy availabil-
ity determining reproductive system function. Such a concept that
wasproposedbyFrisch andRevelle (1970) became further substan-
tiatedwhen leptinwas discovered as a keymessenger fromadipose
tissue to the hypothalamus and controlling the reproductive sys-
tem via stimulation of GnRH secretion (rev in Parent et al., 2003).
As already stated in the introduction, such a mechanism substan-
tiated a putative link between obesity epidemics and earlier onset
of puberty. In the ﬁeld of endocrine disruption, fetal and neonatal
determination of reproductive disorders in adulthood arose four
decades ago following the observations of genital cancer in the
female offspring of mothers treated with DES during pregnancy
(Herbst et al., 1971). Similarly consistent with the early life origins
of diseases, it was suggested recently that obesity and metabolic
syndrome could involve primary peripheral mechanisms through
early impact of nutrition on increased adipogenic and lipogenic
capacity of adipocytes (Muhlhausler and Smith, 2009). Such a con-
cept is consistent with the recent ﬁnding that fast weight gain in
infancy between birth and 9months predicts increased adiposity at
10 years and early menarcheal age (Ong et al., 2009). The hypoth-
esis was also raised that EDC effects on adipose tissue and energy
balance could provide the basis of a toxicological mechanism in
the obesity epidemic (Baillie-Hamilton, 2002; Heindel, 2003). All
together, those ﬁndings indicate that both the human reproduc-
tive system and energy balance system share a possible fetal/early
postnatal determinism of adult disorders under the inﬂuence of
early nutritional conditions and/or early exposure to EDCs.
Ibán˜ez et al. (1998, 2007) reported that intrauterine growth
retardation (IUGR) was associated with increased risk of prema-
ture pubarche, hyperinsulinism, ovarian hyperandrogenism and
polycystic ovary syndrome (PCOS). These ﬁndings can be corre-
latedwith several experimental effects ofmanipulationof nutrition
or exposure to sex steroids or EDCs in the fetus as detailed
above. Of particular interest is the context of this discussion is
the observation that IUGR is associated with increased visceral
adiposity and reduced serum levels of adiponectin in childhood
(Ibán˜ez et al., 2009). The latter effect parallels BPA-induced reduc-
tion of adiponectin production by adipocytes (Hugo et al., 2008;
Ben-Jonathan et al., 2009). In addition, breast-fed IUGR newborns
show lower adiposity and higher serum leptin levels than controls
(Ibán˜ez et al., 2010), an interesting ﬁnding in the face of prevention
of insulin resistance and obesity by postnatal leptin administration
in the rat born IUGR (Vickers et al., 2005).
7. Perspectives
Understandably, the main focus of studies on EDCs has been
the reproductive system for several decades with fertility and
hormone-dependent cancers as the most critical issues. More
recently, genital malformations and disorders of pubertal timing
have emerged as earlier manifestations of a spectrum of distur-
bances all likely to result from EDC effects during the fetal and
neonatal critical age windows. While the interactions between
nutrition and reproduction have been known for decades, it is
only recently that EDCs have appeared to alter the homeostasis
of both reproduction and energy balance. These two systems share
neuroendocrine control in relation with feedback from peripheral
tissues through circulating factors. Further studies should scruti-
nize the common mechanisms and factors possibly linking EDCs
with disturbances of those two systems.
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